Up next

Autoplay

A Q&A On Comprehensive Genomic Profiling in rare cancers and cancer of unknown primary.

4 Views • 07/10/23
Share
Embed
administrator
administrator
Subscribers
0

A Q&A with TargetCancer Foundation on Comprehensive Genomic Profiling and its relevance in rare cancers and cancer of unknown primary, as well as its incorporation in the TRACK Study.

Featuring:
Jim Palma, Executive Director, TargetCancer Foundation
Dr. Prasanth Reddy, VP of Medical Affairs, Foundation Medicine

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay